Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

A gluten-free diet significantly improves skin and health issues in people with dermatitis herpetiformis, a skin condition linked to celiac disease.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

A new mouse model for vitiligo helps study immune responses and potential treatments.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Th22 cells are essential for Tβ15-induced hair growth in mice.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.